CNBC: China’s Digital Health Care Start-ups Get A Boost From The Coronavirus, Beijing And Investors
September 10, 2020
The COVID-19 pandemic has boosted business for Chinese start-ups selling online health consultations and medicine delivery. Before the outbreak, much of the health-tech investment in China was focused on scientific research for medical treatments, said Kitty Lee, Singapore-based partner and head of the Asia Pacific health and life sciences practice at Oliver Wyman. Going forward, she expects the portion of investment focused on consumer health care and infrastructure will grow more rapidly than biotech.
To read the entire article, please click here.